LCD L36021: MolDX: Molecular Diagnostic Tests (MDT) — CGS
Policy LCD-L36021 · Clinical Laboratory
New MolDX policy effective in 2025 may alter billing processes.
Code intelligence
0363U reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code 0363U.
Elevated code risk
Signal breakdown
5 shown · 5 total in platform
Risk: Elevated
0
Critical
0%
5
High
100%
0
Routine
0%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36256: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L36256 · Clinical Laboratory
New molecular diagnostics policy may impact billing processes.
LCD L35160: MolDX: Molecular Diagnostic Tests (MDT) — Noridian
Policy LCD-L35160 · Clinical Laboratory
New MolDX guidelines may alter MDT billing processes.
Proposed LCD DL40380: Urine-based Biomarkers in Patients with Microhematuria — First Coast
Policy LCD-DL40380 · Urology
Proposed LCD on urine biomarkers for microhematuria.
Proposed LCD DL40378: Urine-based Biomarkers in Patients with Microhematuria — Novitas
Policy LCD-DL40378 · Urology
Comment on proposed LCD DL40378 by July 18, 2026.
Audit documentation
Building an audit file that includes 0363U?
The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription